Novocaine

Quick links to important sections

Novocaine

Selected form

Method of action: Anesthetic, Local Anesthetic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novocaine

Quick Facts

Feature Detail
Active Ingredient (INN) Procaine
Drug Class Local Injectable Anesthetic (Amino Ester)
Mechanism Sodium Channel Blocker
Status Prescription Only (Rx)

Novocaine is the original brand name for the drug procaine hydrochloride, which is an injectable local anesthetic. Chemically, procaine belongs to the amino ester class of local anesthetics and is a synthetic derivative of para-aminobenzoic acid (PABA). It is used to produce temporary loss of feeling (numbness) in a specific, localized area of the body for surgical, dental, or medical procedures.

Procaine was first synthesized in 1905 by German chemist Alfred Einhorn and was quickly introduced into medical practice as a replacement for the previously used local anesthetic, cocaine, which carried a high risk of dependence and toxicity. The trade name Novocain (from the Latin nov- meaning 'new' and -caine), gained such widespread recognition that the name is still used in popular culture as a generic term for any dental or local anesthetic injection, despite the original brand being largely superseded in modern practice.


Therapeutic Use and Differentiation

Procaine functions by stabilizing the neuronal membrane, which prevents the generation and conduction of nerve impulses, thereby achieving local anesthesia. Its efficacy is confirmed by its inclusion in various official formularies for local and regional nerve block techniques, such as spinal anesthesia, a method supported by long-standing clinical practice. A common, neutral use scenario is its administration to achieve temporary numbness before a minor surgical intervention or a dental procedure.

While highly effective and revolutionary at the time of its discovery, Novocaine is characterized by a relatively slow onset and short duration of action compared to newer local anesthetics. Furthermore, procaine is metabolized in the body into PABA, which carries a higher potential for allergic reactions in some individuals compared to the amide-type anesthetics (like lidocaine) that were later developed. Consequently, while it remains approved, other agents have become the preferred choice for many contemporary procedures, particularly in dentistry.

Regulatory References

  1. NIH: Procaine StatPearls

What side effects are possible with Novocaine?

Possible Side Effects and Safety Information for Novocaine (Procaine)

The use of Novocaine, an ester-type local anesthetic, involves a safety profile primarily defined by the risk of systemic toxicity and hypersensitivity reactions.

Serious and Clinically Significant Adverse Reactions

Adverse experiences are generally dose-related and result from high levels of the drug in the bloodstream, which may occur from excessive dosage, rapid absorption, or unintentional injection into a blood vessel. The most critical adverse reactions involve the Central Nervous System (CNS) and the Cardiovascular System (CVS).

System-Organ Class Reactions
Central Nervous System Restlessness, anxiety, dizziness, tremors, and, in severe cases, convulsions, followed by drowsiness, unconsciousness, and respiratory arrest.
Cardiovascular System Myocardial depression, pronounced bradycardia, severe hypotension, and, rarely, cardiac arrest.
Immune System Allergic reactions, including rare but severe anaphylactoid-like symptoms, urticaria (hives), and angioedema.

Safety Considerations and Restrictions

Systemic toxicity requires immediate medical management. The risk of serious adverse effects is dependent on the total dose administered and the patient's physical status. Special caution and reduced doses are necessary for elderly, acutely ill, or debilitated patients.

Novocaine is contraindicated in individuals with a known hypersensitivity to ester-type local anesthetics or its metabolic derivative, para-aminobenzoic acid (PABA). Caution is also advised in patients with pre-existing conditions such as severe disturbances of cardiac rhythm, shock, or heart block, as these may heighten the risk of cardiovascular adverse events. The lowest dosage required for effective local anesthesia should always be used.

Overdose and Emergency Response

Overdose Manifestations and Progression

Overdose is described in regulatory labeling as dose-related systemic toxicity, primarily impacting the central nervous and cardiovascular systems. The documented presentation involves a progression of Central Nervous System (CNS) effects. This typically begins with an excitation phase, which includes signs such as restlessness, anxiety, dizziness, tremors, and may progress to convulsions. This initial phase is succeeded by CNS depression, marked by drowsiness that can lead to unconsciousness and respiratory arrest.

Severe Outcomes and When to Seek Help

Systemic toxicity can lead to severe cardiovascular adverse outcomes, including myocardial depression, heart block, hypotension, and life-threatening ventricular arrhythmias, potentially resulting in cardiac arrest. Regulatory authorities require the application of immediate countermeasures for all acute CNS and cardiovascular adverse experiences. Urgent medical attention is required, as the labeling notes that a delay in proper management is a factor that may lead to acidosis, cardiac arrest, and death.

Population Considerations

The risk of toxicity may be increased in certain patient groups. Diminished tolerance is noted for patients with factors that influence plasma protein binding, such as Plasma Cholinesterase Deficiency or systemic acidosis. A specific antidote for systemic procaine toxicity is not explicitly listed in the official prescribing information.

Therapeutic Uses of Novocaine

What Novocaine Treats: Main Uses and Benefits

Novocaine (procaine) is commonly used for supporting local or regional symptomatic relief and pain management. It is generally applied across therapeutic domains by healthcare providers in situations involving symptoms related to physical discomfort.

Supportive Symptom Management

The medicine is used when short-term symptomatic assistance is needed across conditions characterized by periods of heightened symptoms. It is applied in clinical settings that involve acute or unstable symptom patterns, such as during minor surgical procedures or dental work. Novocaine plays a role in managing symptoms related to inflammatory or irritative states. It helps address symptom clusters that create noticeable physiological strain, which supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Localized Discomfort

Novocaine assists with maintaining functional stability and contributing to improved comfort when symptoms interfere with routine activities during clinical procedures.

Regulatory References

  1. FDA-Approved Labeling for Novocain

Eligibility and Restrictions for Use

Who Must Not Use Novocaine (Contraindications)

Procaine (Novocaine) eligibility is strictly determined by regulatory labeling, focusing on patient status and allergies.

Use is contraindicated for any patient with a known allergy to procaine, para-aminobenzoic acid (PABA), or other ester-type local anesthetics. It is also strictly prohibited for use in patients experiencing severe shock or circulatory collapse. Specific anesthesia techniques, such as spinal block, have additional contraindications, including severe hypotension.

Conditional Use and Restrictions

Eligibility is conditional for patients with certain systemic conditions. Caution is advised for those with severe renal impairment, reduced liver function, or a documented deficiency of pseudocholinesterase, as these can impair the drug’s metabolism or elimination. Patients with severe cardiovascular conditions, including heart block, must also be approached with caution.

Age-Group and Physiological Eligibility

Adults are generally eligible for use under standard labeled conditions. Older adults require cautionary administration and often a reduced dosage due to physiological changes. For pediatric patients, use is conditional upon careful, weight-based calculation; regulatory bodies note that safety for some nerve block techniques may not be formally established. For pregnant or lactating patients, use is restricted to instances where the potential benefit demonstrably outweighs the potential risk.

What should I know about interactions with other medicines?

Novocaine (procaine) can interact with a variety of other medications and substances, potentially altering its effect or increasing the risk of side effects. It is vital to inform your healthcare provider of all prescription and over-the-counter medicines, supplements, and herbal products you are currently taking.

Potential Drug Interactions

Drug/Drug Class Potential Effect
Sulfa Drugs (Sulfonamides) Procaine is metabolized into para-aminobenzoic acid (PABA), which can antagonize the antibacterial action of sulfonamide antibiotics (e.g., sulfamethoxazole).
Acetylcholinesterase Inhibitors When used alongside agents that inhibit acetylcholinesterase, the effects of Novocaine may be prolonged or enhanced.
Other Local Anesthetics Combination use of Novocaine with other local anesthetics is not generally recommended due to an increased risk of systemic toxicity.
Methemoglobin-Inducing Agents Combining Novocaine with other drugs that can cause methemoglobinemia (such as acetaminophen, nitrates, and nitrites) increases the risk of this serious blood disorder.

Additionally, Novocaine solutions that contain a vasoconstrictor, such as epinephrine, must be used with extreme caution with medications like ergot-type oxytocic drugs, tricyclic antidepressants, and Monoamine Oxidase Inhibitors (MAOIs), as severe or prolonged hypertension or cardiac rhythm disturbances may occur.

Mechanism of Action

Sodium Channel Inhibition: The Mechanism of Action

Novocaine (Procaine) functions as a reversible inhibitor by targeting voltage-gated sodium channels (NaV channels) located on peripheral nerve membranes. The drug, in its ionized form, binds to a specific site within the open or inactivated pore of the channel, physically obstructing it. This molecular block prevents the necessary influx of sodium ions (Na^+) required for membrane depolarization.

This inhibition halts the Action Potential propagation pathway, thereby facilitating a conduction block in the peripheral sensory nerves. This local interruption of the electrical signal prevents impulses from transmitting to the central nervous system, leading directly to the physiological consequence of localized functional sensory nerve impairment (nociceptive signal abolition).

Notably, the drug's access to its intracellular target is constrained by the local tissue pH. Environments of acidosis (e.g., inflammation) increase drug ionization outside the nerve, impeding membrane penetration and resulting in a reduced local effect of the conduction block.

Dosage and Administration Information

How to Use Novocaine

Novocaine (procaine hydrochloride) is used exclusively as a single-dose injection to induce localized anesthesia for medical or surgical procedures, and is not a scheduled, long-term medication. Its administration is restricted to a controlled, clinical setting by or under the supervision of experienced clinicians.


Official Administration Routes and Dosing

Parameter Instruction
Route of Administration Restricted to injection via local infiltration, peripheral nerve block, or intraspinous (spinal) routes.
Dosing Schedule A maximum single administration dose should not exceed 1,000 mg of procaine. The specific total dose is highly variable, ranging from 50 mg to 200 mg for spinal anesthesia and up to 600 mg for infiltration, depending on the technique and concentration used.
Time Pattern Administration results in a rapid onset of action (2–5 minutes) and a short duration of effect, typically lasting 1 to 1½ hours.

Preparation and Procedural Constraints

The 10% solution used for spinal anesthesia must be diluted with a sterile solution, such as normal saline or spinal fluid, prior to injection. The solution may also have a vasoconstrictor added to delay systemic absorption and extend the anesthetic effect.

Administration involves a specific technique: the injection must be performed slowly and must include frequent aspiration (drawing back on the syringe) before and during the injection to ensure the needle is correctly placed and to prevent accidental injection into a blood vessel. Doses must be reduced for older adults, the acutely ill, or debilitated patients, adjusting the amount to their physical status. For pediatric patients undergoing local infiltration, a weight-based maximum dose of 15 mg/kg of a 0.5% solution is specified.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Procaine (Novocaine)

Procaine, the active ingredient in Novocaine, has been studied since 1905 and is part of the clinical research record. The available evidence, which includes foundational observations and modern comparative trials, contributes to understanding how patients reported their experience of localized numbness during various procedures.


Evidence for Use in Local Anesthesia for Minor Procedures

The primary research for procaine was studied for temporary, localized sensory loss for short, minor procedures, such as specific dental work. Foundational evidence includes historical clinical observations and its long-standing regulatory status. Recent Randomized Controlled Trials (RCTs) monitored the time measured until block onset and the total duration of the measured sensory block. Studies designed to compare procaine to other anesthetic agents reported measurements indicating a shorter duration of the anesthetic effect. The available studies primarily included adult patients undergoing outpatient care, particularly dental patients.

Evidence for Use in Regional Anesthesia

Procaine was also evaluated in clinical settings involving regional anesthesia, specifically when administered into the spinal fluid space for brief surgical procedures. This research consists of RCTs and Comparative Trials that explored how procaine was evaluated alongside alternative agents. Findings indicated a generally shorter duration when compared to many agents observed in the same setting, and studies suggest its application is primarily related to very short surgical procedures.


Long-Term Data and Research Uncertainty

Research is focused entirely on short-term outcomes that resolve within a few hours. Consequently, long-term effects are not fully established, as follow-up is typically limited to the immediate post-recovery period. Most research has been performed in generally healthy adult surgical and dental patients. Data for certain groups, such as children, older adults, or those with complex comorbid conditions, remain insufficient. The short duration of action is consistently noted, which may be associated with constraints on its application in some settings.

Key Studies & References

  1. FDA-Approved Labeling for NOVOCAIN (Procaine Hydrochloride Injection)
  2. Procaine. StatPearls [Internet].
  3. Comparative efficacy of local anesthetics in minor surgical procedures: a systematic review.
  4. Local anesthetics in pediatric dentistry: a review of current evidence and future directions.

Frequently Asked Questions (FAQ)

Common questions about Novocaine (FAQ)


Q: What happens if I drink water or eat right after getting Novocaine?

A: Local anesthetics like Novocaine can cause numbness in the tongue and lips, and this effect can last for several hours. According to patient counseling information, to avoid accidental injury such as biting or burning the numb area, it is usually advised not to eat or drink until normal sensation has returned to the area.


Q: Does Novocaine contain latex?

A: Official regulatory guidelines require a warning statement if a medical product, its container, or its packaging is made with natural rubber latex. If a person has a latex allergy, the specific package labeling should be checked, or the healthcare provider should be consulted, as this information is subject to manufacturing safety standards.


Q: How long does Novocaine stay in the body after the numbness wears off?

A: The active ingredient in Novocaine, procaine, is metabolized (broken down) very quickly in the blood by natural body enzymes. Official pharmacological data indicate that its elimination half-life—the time it takes for the amount of drug in the body to be halved—is very short, approximately 7.7 minutes.


Q: Is it true that Novocaine can affect driving temporarily?

A: Official product information notes that the use of Novocaine can sometimes cause central nervous system (CNS) effects, such as dizziness and drowsiness. Due to this potential for temporary impairment of attention and coordination, caution regarding driving or operating complex machinery is typically mentioned in counseling information.


Q: Is there a reversal agent for Novocaine?

A: While Novocaine itself is designed to wear off quickly, certain reversal agents have been developed and approved to help accelerate the return of normal sensation after local dental anesthesia. These agents are used primarily when the local anesthetic solution contains a vasoconstrictor.


Q: Are there any dietary restrictions mentioned for before or after receiving Novocaine?

A: Official patient counseling information primarily focuses on post-procedure caution. To prevent accidental injury while the numbing is active, patients are generally advised to avoid chewing and to consume soft foods until the anesthetic has worn off.


Q: Can Novocaine be used on patients taking blood thinners?

A: The regulatory label advises caution in patients with underlying bleeding or blood clotting problems. This caution is due to the injection technique itself, as there is a risk of hemorrhage (bleeding) or hematoma (bruising) associated with the needle insertion. The specific use of Novocaine in patients taking blood thinners is a clinical consideration requiring assessment of the patient’s status.


Q: Is Novocaine considered addictive?

A: Procaine (Novocaine) is not classified as a controlled substance by the U.S. Drug Enforcement Administration and its international counterparts. Official drug descriptions note that it has no known addictive or euphoric qualities.


Q: What do official sources say about Novocaine and underlying neurological conditions?

A: Official regulatory documents advise caution and dose reduction in patients with certain diseases of the central nervous system. These conditions may be associated with an altered sensitivity or reduced tolerance to local anesthetics, which is why official documents advise caution.


Q: How does the feeling of Novocaine wearing off typically occur?

A: The numbing sensation from Novocaine resolves gradually as the drug is metabolized. As normal feeling returns to the affected area, patients commonly experience a tingling or 'pins-and-needly' sensation, according to patient counseling information.


Q: Is Novocaine used in veterinary medicine?

A: Yes, procaine—the active ingredient in Novocaine—is included in some veterinary formulations of local anesthetics. Regulatory bodies like the European Medicines Agency have established guidelines for its use in various animal species.


Q: What should be done if the numbness from Novocaine lasts longer than expected?

A: The expected duration of effect is typically short, lasting 1 to 1.5 hours. If the numbness persists significantly longer than the expected timeframe, regulatory guidance indicates this should be brought to the attention of the healthcare provider. This is done to help rule out nerve irritation or other complications.


Q: Can Novocaine affect my blood sugar levels?

A: Novocaine solutions may contain the added vasoconstrictor epinephrine. Epinephrine is known to have physiological effects that can cause a transient elevation in blood sugar levels. This physiological effect is a factor that must be considered by the administering clinician, particularly for patients with diabetes.


Q: Does Novocaine have any ingredients that are related to adrenaline?

A: Solutions of Novocaine are sometimes combined with a vasoconstrictor to prolong the numbing effect. This added vasoconstrictor is often epinephrine, which is the pharmaceutical name for the substance commonly known as adrenaline. This addition must be noted by the clinician due to its systemic effects.


Q: Can Novocaine interact with blood pressure medications?

A: Novocaine solutions that contain epinephrine (adrenaline) must be used with caution alongside certain medications, including some drugs that affect blood pressure, like tricyclic antidepressants (TCAs) and MAOIs. The potential risks of interaction with a patient's full medication list are evaluated by the clinician prior to administration.


Q: How is Novocaine different from general anesthesia?

A: Novocaine is a form of localized anesthesia, meaning its function is to cause a temporary loss of sensation or numbness in a specific, limited area of the body. This is distinct from general anesthesia, which involves a controlled, temporary state of unconsciousness and loss of sensation throughout the entire body.


Q: Can Novocaine interact with herbal supplements?

A: Regulatory documents advise patients to inform their healthcare provider of all prescription medicines, over-the-counter drugs, supplements, and herbal products they are taking. The potential for interaction is why official guidelines advise disclosing all supplements to the healthcare provider for assessment.


Q: Is Novocaine used for pain relief after a procedure?

A: The primary function of Novocaine is to induce temporary local numbness during a medical or surgical procedure. Because the drug has a relatively short duration of action—typically 1 to 1.5 hours—it is not intended or used as a long-acting medication for managing pain that occurs after the procedure.


Q: What is the difference between Novocaine and an epidural?

A: Novocaine is an anesthetic drug approved for use in specific injection methods, including local infiltration, peripheral nerve blocks, and spinal (intraspinous) block. An epidural is a different type of regional anesthesia technique, and Novocaine's regulatory label does not include its use specifically for the epidural space.


Q: What kind of dental procedures use Novocaine?

A: Research and foundational evidence for procaine (Novocaine) primarily involve its use for temporary, localized sensory loss during short, minor procedures. This includes specific dental procedures where only a limited area requires numbness for a brief duration.


Q: What research exists about Novocaine and nerve damage?

A: Official documents define Novocaine's action as a reversible inhibitor that creates a temporary 'conduction block' in the nerves. The regulatory safety profile for Novocaine focuses on acute, short-term outcomes resolved within hours, and the potential for neurotoxicity is a key consideration when using this type of local anesthetic.

How should Novocaine be stored and disposed of?

Storage and Disposal Requirements for Procaine Hydrochloride Injection

The storage and disposal of Procaine Hydrochloride injection (Novocaine) must adhere strictly to official regulatory standards to maintain product integrity and safety.

Storage Conditions and Stability

The solution must be visually examined carefully before use. Healthcare providers must not use the injection if there are any signs of instability, such as the presence of crystals, cloudiness, or discoloration, as these indicate the product quality is compromised. The product must be stored and handled in a manner that keeps it out of the reach of children, following mandatory safety requirements for all prescription medications.

Official Disposal Rules

Disposal of any unused or expired injection must be carried out according to official local regulations. To prevent environmental hazards, the product should not be allowed to reach the sewage system or water course, especially where bulk material disposal is concerned.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novocaine found in:

A-Z Index: